Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H10FN3 |
| Molecular Weight | 262.2716 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[18F]C1=CC=C(C=N1)C2=CC=C3C(NC4=C3C=NC=C4)=C2
InChI
InChIKey=GETAAWDSFUCLBS-SJPDSGJFSA-N
InChI=1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H/i17-1
| Molecular Formula | C16H10FN3 |
| Molecular Weight | 262.2716 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Flortaucipir (18F-AV-1451, also known as 18F-T807) is a highly selective positron emission tomography (PET) imaging agent targeting paired helical filament (PHF)-tau in the brain. This tracer is studying for clinical assessment in patients with various tauopathies, including Alzheimer's disease, as well as in healthy subjects.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| 18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease. | 2018-02 |
|
| Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden. | 2017-12-01 |
|
| Quantification of Tau Load Using [18F]AV1451 PET. | 2017-12 |
|
| 18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study. | 2017-10 |
|
| Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex. | 2017-07-01 |
|
| Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia. | 2017-04-11 |
|
| Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. | 2017-03-01 |
|
| Tau PET imaging: present and future directions. | 2017-02-20 |
|
| Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease. | 2016-10 |
|
| Synthesis and quality control of [(18) F]T807 for tau PET imaging. | 2016-08 |
|
| [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. | 2013-11 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28077397
Flortaucipir PET images were acquired for 20 min, as four 5-min frames, beginning 80 min after injection of 370 MBq flortaucipir. On a separate day, subjects underwent a florbetapir PET scan for 10 min, as two 5-min frames, beginning 50 min after injection of 370 MBq florbetapir F18.
Route of Administration:
Parenteral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:53:50 GMT 2025
by
admin
on
Mon Mar 31 22:53:50 GMT 2025
|
| Record UNII |
T1JP1KYU9O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
70957463
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
DB14914
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
Flortaucipir (18F)
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
m12220
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
CD-33
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
1522051-90-6
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
DTXSID001027893
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
10203
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
100000178384
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
T1JP1KYU9O
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
CHEMBL3546271
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
T1JP1KYU9O
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
2372689
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY | |||
|
C171887
Created by
admin on Mon Mar 31 22:53:50 GMT 2025 , Edited by admin on Mon Mar 31 22:53:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->RADIOLIGAND |
Images aggregates
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|